Pipelines

Promosome has granted GE Healthcare exclusive rights for to its mammalian cell line technologies

GE to in-license Promosome mammalian cell lines

By Zachary Brennan

GE Healthcare Life Sciences has signed a licensing agreement for Promosome’s suite of mammalian cell line development technologies, which aim to increase protein expression in mammalian cell culture. 

Follow us

Products

View more

Webinars